Clara is a simple, yet highly-sensitive digital app that identifies early-stage mild cognitive impairment and Alzheimer’s disease with unprecedented precision and ease. The assessment targets the core disorder in Alzheimer’s disease in a personalized manner. Recent lab progress includes studies of patients under multimodal neuroimaging, a large scale study in China and collaboration with several worldwide ongoing studies.